MRD Assay Materials and Processing Services

The University of Calgary (UCalgary) CTRC Lab requires assay materials and processing services to support research with minimal residual disease (MRD) testing in Multiple Myeloma. UCalgary’s objective is to contract with a service provider who can achieve ultra-high sensitivity results able to detect one malignant cell among one million healthy cells (10-6). In accordance with these requirements, UCalgary intends to purchase the clonoSEQ MRD assay materials and processing services from Adaptiv